CA Stock MarketDetailed Quotes
DHB Delivra Health Brands Inc
- 0.025
- -0.005-16.67%
15min DelayTrading Aug 2 09:50 ET
7.82MMarket Cap-8333P/E (TTM)
0.030High0.025Low25.86KVolume0.030Open0.030Pre Close710.74Turnover0.05552wk High0.01%Turnover Ratio312.62MShares0.01552wk Low-0.003EPS TTM5.52MFloat Cap0.055Historical HighLossP/E (Static)220.89MShs Float0.010Historical Low-0.001EPS LYR16.67%Amplitude--Dividend TTM2.27P/B1Lot Size--Div YieldTTM
Delivra Health Brands Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 140.67%290K | -8.57%-494K | -16.58%156K | 75.50%-1.09M | 80.15%-107K | 29.96%-713K | 76.22%-455K | 119.26%187K | 53.96%-4.44M | 60.71%-539K |
| Net income from continuing operations | 58.92%-281K | -114.29%-40K | -268.58%-381K | 97.37%-184K | 99.73%-6K | 59.21%-684K | 117.19%280K | 115.54%226K | 75.44%-7.01M | 74.39%-2.25M |
| Operating gains losses | 103.14%24K | 104.57%30K | -79.63%11K | -424.24%-1.5M | 14.47%-130K | -222.40%-765K | -742.31%-657K | -19.40%54K | 1,258.82%462K | 58.70%-152K |
| Depreciation and amortization | -2.11%325K | -0.91%327K | -0.60%332K | -37.23%1.33M | -36.62%334K | -37.12%332K | -37.38%330K | -37.80%334K | -20.28%2.12M | -4.53%527K |
| Asset impairment expenditure | -67.96%99K | 164.81%143K | -87.18%10K | -66.10%398K | -106.65%-43K | -22.17%309K | -58.46%54K | --78K | -93.09%1.17M | -88.72%647K |
| Unrealized gains and losses of investment securities | --0 | -128.57%-2K | --2K | 103.09%15K | --2K | 101.01%6K | 120.59%7K | --0 | -180.60%-486K | --0 |
| Remuneration paid in stock | --0 | -130.43%-35K | 3,700.00%38K | -56.82%152K | -56.90%25K | -81.03%11K | 32.18%115K | -99.33%1K | -38.99%352K | -82.84%58K |
| Other non cashItems | -93.95%51K | 135.39%339K | -346.48%-175K | -70.47%75K | -1.65%119K | 1,104.29%843K | -1,529.85%-958K | 1,875.00%71K | -6.27%254K | --121K |
| Change In working capital | 109.41%72K | -435.83%-1.26M | 155.29%319K | -5.28%-1.38M | -180.16%-408K | -80.85%-765K | 138.05%374K | -40.73%-577K | 41.81%-1.31M | -35.97%509K |
| -Change in receivables | -61.22%121K | -102.57%-21K | 118.50%173K | -281.94%-867K | -514.84%-1.06M | 155.12%312K | 1,068.57%818K | -7,292.31%-935K | -120.30%-227K | -77.22%256K |
| -Change in inventory | 109.80%10K | 133.77%364K | -104.85%-16K | 34.87%-467K | 173.09%383K | -157.95%-102K | -223.72%-1.08M | 1,016.67%330K | -131.59%-717K | -168.23%-524K |
| -Change in prepaid assets | -119.47%-22K | 76.70%-41K | -73.08%7K | -123.85%-78K | -116.80%-41K | -43.50%113K | -32.33%-176K | 62.50%26K | -22.51%327K | -9.29%244K |
| -Change in payables and accrued expense | 96.60%-37K | -292.35%-1.56M | 7,650.00%155K | 105.22%36K | -41.46%312K | -366.95%-1.09M | 237.99%810K | 100.50%2K | 88.57%-690K | 139.02%533K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 140.67%290K | -8.57%-494K | -16.58%156K | 75.50%-1.09M | 80.15%-107K | 29.96%-713K | 76.22%-455K | 119.26%187K | 53.96%-4.44M | 60.71%-539K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 115.78%2.91M | -35K | -101.10%-6K | -89.00%1.35M | 0 | ||||
| Net PPE purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 1,275.00%94K | --0 |
| Net intangibles purchas and sale | ---- | ---- | ---- | -241.67%-41K | ---35K | ---- | ---- | ---- | ---12K | --0 |
| Net investment purchase and sale | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 23.47%1.27M | --0 |
| Net other investing changes | ---- | ---- | ---- | --2.95M | --0 | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | -99.63%11K | --0 | 115.78%2.91M | ---35K | -101.10%-6K | 49,333.33%2.95M | --0 | -89.00%1.35M | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 6.45%-58K | 1,395.00%777K | -23.21%-69K | 17.48%-255K | 32.46%-77K | 1.59%-62K | -3.45%-60K | 24.32%-56K | -169.28%-309K | 69.44%-114K |
| Net issuance payments of debt | 6.45%-58K | 30.00%-42K | -23.21%-69K | 17.48%-255K | 32.46%-77K | 1.59%-62K | -3.45%-60K | 24.32%-56K | 92.43%-309K | 47.95%-114K |
| Net common stock issuance | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 6.45%-58K | 1,395.00%777K | -23.21%-69K | 17.48%-255K | 32.46%-77K | 1.59%-62K | -3.45%-60K | 24.32%-56K | -169.28%-309K | 69.44%-114K |
| Net cash flow | ||||||||||
| Beginning cash position | -18.14%3.08M | -57.24%1.25M | -60.16%1.08M | -75.54%1.08M | 76.77%2.92M | 68.57%3.76M | -31.05%2.91M | -38.59%2.72M | 215.15%4.43M | -68.75%1.65M |
| Current changes in cash | 129.71%232K | -87.95%294K | -33.59%87K | 146.18%1.57M | 66.46%-219K | -45.71%-781K | 223.37%2.44M | 155.98%131K | -210.82%-3.4M | 39.70%-653K |
| Effect of exchange rate changes | 239.68%88K | -332.56%-100K | 20.97%75K | 26.42%67K | -71.59%25K | -40.00%-63K | 326.32%43K | 113.79%62K | 223.26%53K | -63.03%88K |
| End cash Position | 16.54%3.4M | -18.14%3.08M | -57.24%1.25M | 151.01%2.72M | 151.01%2.72M | 76.77%2.92M | 68.57%3.76M | -31.05%2.91M | -75.54%1.08M | -75.54%1.08M |
| Free cash from | 140.33%290K | -8.57%-494K | -16.58%156K | 74.70%-1.13M | 73.65%-142K | 29.65%-719K | 76.29%-455K | 119.02%187K | 53.89%-4.46M | 60.86%-539K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg